American Medical Rehabilitation Providers Association

Association of medical rehabilitation hospitals and providers

Based in IL

🤖

AI Overview

With $1.8M in lobbying spend across 12 quarterly filings, American Medical Rehabilitation Providers Association is a significant lobbying presence.

$1.8M
Total Lobbying Spend
12
Quarterly Filings
1
Lobbying Firms Used
6
Individual Lobbyists

Spending by Year

YearLobbying Spend
2018$630K
2019$610K
2020$540K

Lobbying Firms

AKIN GUMP STRAUSS HAUER & FELD

What They Lobby For

  • Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; therapy caps reauthorization/repeal; implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement (CCJR) Model; managed care related issues; value based purchasing issue, Recovery Audit Contractor issues, Balanced Budget Act of 2018.
  • Funding related to continuing care hospitals; implementation of IRF payment.
  • Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; therapy caps reauthorization/repeal; implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement (CCJR) Model; managed care related issues; value based purchasing issue, Recovery Audit Contractor issues, Balanced Budget Act of 2018; FY 2019 IRF IPPS issues with PPS, proposed Rules; regulatory reform and red tape initiatives.
  • Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; therapy caps reauthorization/repeal; implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement (CCJR) Model; managed care related issues; value based purchasing issue, Recovery Audit Contractor issues, Balanced Budget Act of 2018; FY 2019 IRF IPPS issues with PPS proposed Rules; regulatory relief/reform and red tape initiatives.
  • Funding related to continuing care hospitals; IRF payment and coverage; regulatory relief and reform issues.
  • Unified post-acute care payment system; Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; therapy caps reauthorization/repeal; implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement (CCJR) Model; managed care related issues; value based purchasing issue, Recovery Audit Contractor issues, Balanced Budget Act of 2018; FY 2019 IRF IPPS issues with PPS, proposed rulemaking FY 2019 IPPS excluded hospitals operation of excluded units; and ways and means red tape reduction initiative.
  • Unified post-acute care payment system; Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; therapy caps reauthorization/repeal; implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement (CCJR) Model; managed care related issues; value based purchasing issue, Recovery Audit Contractor issues, Balanced Budget Act of 2018; FY 2019 IRF IPPS issues with PPS, proposed rulemaking FY 2019 IPPS excluded hospitals operation of excluded units; and ways and means red tape reduction initiative; LTCH exempt unit issue.
  • Issues related to continuing care hospitals; IRF payment and coverage; Prior Authorization; regulatory relief and reform issues; unified post-acute care payment systems.
  • Unified post-acute care payment system; Prior Authorization; Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; value based purchasing issue, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitalsoperation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue.
  • Unified post-acute care payment system; Prior Authorization; Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; value based purchasing issue, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue.

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.